Alcohol-Related Esophageal Cancer Risk Is Reversible

This article originally appeared here.
Share this content:
Alcohol-Related Esophageal Cancer Risk Is Reversible
Alcohol-Related Esophageal Cancer Risk Is Reversible

(HealthDay News) -- The alcohol-related effects on esophageal cancer risk are reversible with cessation of alcohol consumption, according to research published in the July issue of Addiction.

Johan Jarl, Ph.D., and Ulf-G Gerdtham, Ph.D., from Lund University in Malmö, Sweden, conducted a literature review and identified 17 studies that estimated the risk reduction after quantified drinking cessation. Nine studies were included in the meta-analysis.

The researchers noted a large degree of heterogeneity between the studies, but this was explainable. A common trend in the studies was the reversibility of the increased risk of esophageal cancer caused by alcohol consumption, with a required time period of 16.5 years (95 percent confidence interval, 12.7 to 23.7) until no risk from former drinking remained. This estimation might be an overestimation due to sample characteristics. There was exponential decay with the dose-response relationship, meaning that about half the reduction in alcohol-related risk occurred after just a third of the time period required to eliminate the additional risk.

"The alcohol-related increased risk of esophageal cancer is reversible following drinking cessation. It is most likely that about 16 years are required until all elevated risk has disappeared," the authors conclude. "Due to lack of research and data, more research is urgently required to increase the robustness of the estimates and to approach study limitations."


Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs